Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:LABS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLABSMediPharm LabsC$0.08-6.3%C$0.09C$0.06▼C$0.12C$31.13M0.88345,797 shs26,759 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLABSMediPharm Labs0.00%-16.67%-16.67%+15.38%-6.25%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLABSMediPharm LabsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLABSMediPharm Labs 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLABSMediPharm LabsC$39.42M0.79C$0.06 per share1.30C$0.11 per share0.68Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLABSMediPharm Labs-C$12.05M-C$0.03N/A∞N/A-30.56%-24.41%-7.17%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLABSMediPharm LabsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLABSMediPharm Labs1.453.213.10Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLABSMediPharm Labs0.71%Insider OwnershipCompanyInsider OwnershipLABSMediPharm Labs4.45%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLABSMediPharm Labs130415.00 millionN/ANot OptionableIHR, PHP, THRL, and LABS HeadlinesRecent News About These CompaniesMediPharm Labs Corp.: MediPharm Labs Cautions Shareholders about Dissident Nominees' Governance Failures at Check-Cap Ltd.May 24 at 6:45 AM | finanznachrichten.deMediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.May 23 at 5:20 PM | finance.yahoo.comMediPharm Labs Corp.: MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in JuneMay 22 at 11:28 AM | finanznachrichten.deMediPharm Labs Corp.: MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation FilingsMay 22 at 11:28 AM | finanznachrichten.deEarnings call transcript: Medipharm Labs reports first positive EBITDA in Q1 2025May 16, 2025 | uk.investing.comMediPharm Labs Corp.April 1, 2025 | baystreet.caMediPharm Labs to sell its Hope, B.C. facility for $4.5MMarch 4, 2025 | canadianmanufacturing.comMediPharm Labs to Sell its Hope Facility to Rubicon Organics for $4.5MMarch 3, 2025 | finance.yahoo.comMediPharm Labs scraps C$5.5M Ontario facility sale to Kensana HealthFebruary 10, 2025 | greenmarketreport.comMedipharm Labs Terminates Facility Sale to Kensana HealthFebruary 10, 2025 | marketwatch.comMediPharm Labs terminates proposed sale of Napanee facility to Kensana HealthFebruary 10, 2025 | seekingalpha.comANVISA approves MediPharm Labs’ cannabis products for Brazilian marketJanuary 8, 2025 | canadianmanufacturing.comMediPharm Labs: Top 10 Undervalued Healthcare Sector Stocks on TSX (LABS)January 8, 2025 | theglobeandmail.comStockTalk | Cannabis Report: The Holiday EditionDecember 20, 2024 | msn.comXORTX Appoints Michael Bumby As CFO, Replacing James FairbairnDecember 19, 2024 | markets.businessinsider.comMediPharm labs selling Napanee facilityDecember 17, 2024 | quintenews.comMediPharm Labs sells Ontario facility for C$5.5M as part of streamlining planDecember 17, 2024 | greenmarketreport.comMediPharm Labs Corp. to sell its facility to Kensana HealthDecember 17, 2024 | canadianmanufacturing.com3 TSX Penny Stocks With Market Caps Under CA$30M To ConsiderNovember 13, 2024 | finance.yahoo.comThe Market Online’s Weekly Cannabis Report – Oct. 25, 2024October 25, 2024 | msn.comMedia Sentiment Over TimeIHR, PHP, THRL, and LABS Company DescriptionsMediPharm Labs TSE:LABSC$0.08 -0.01 (-6.25%) As of 05/23/2025 03:58 PM EasternMediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4. Its geographical segments are Canada and Australia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain These ETFs Provide Easy Exposure to Growing International Markets Advance Auto Parts Jumps on Surprise Earnings Beat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
